Alpha Tau Medical to Present New Data at ASCO GI Symposium
Ticker: DRTSW · Form: 6-K · Filed: Dec 18, 2024 · CIK: 1871321
| Field | Detail |
|---|---|
| Company | Alpha Tau Medical Ltd. (DRTSW) |
| Form Type | 6-K |
| Filed Date | Dec 18, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: announcement, data presentation, medical technology
TL;DR
Alpha Tau presenting new data at ASCO GI Symposium in 2025.
AI Summary
Alpha Tau Medical Ltd. announced on December 18, 2024, that it will present new data at the 2025 ASCO GI Symposium and at its upcoming R&D Update Day. The press release detailing this information is attached as Exhibit 99.1 to their Form 6-K filing.
Why It Matters
This announcement signals potential advancements in Alpha Tau's medical technology, which could impact future treatment options and the company's market position.
Risk Assessment
Risk Level: low — The filing is an announcement of upcoming data presentations, not a financial event or material change in operations.
Key Players & Entities
- Alpha Tau Medical Ltd. (company) — Registrant
- 2025 ASCO GI Symposium (event) — Presentation venue
- December 18, 2024 (date) — Announcement date
FAQ
What specific new data will Alpha Tau Medical Ltd. present?
The filing does not specify the exact nature of the new data to be presented, only that it will be shared at the 2025 ASCO GI Symposium and the Company R&D Update Day.
When is the 2025 ASCO GI Symposium scheduled to take place?
The filing mentions the 2025 ASCO GI Symposium but does not provide the specific dates for the event.
Has Alpha Tau Medical Ltd. provided a date for their R&D Update Day?
The filing announces the upcoming R&D Update Day but does not specify a date for this event.
What is the purpose of attaching the press release as Exhibit 99.1?
The press release is attached to the Form 6-K to provide the details of the announcement regarding upcoming data presentations.
Is the information in this Form 6-K considered 'filed' with the SEC?
No, the filing explicitly states that the information in this Report on Form 6-K, including Exhibit 99.1, is being furnished and shall not be deemed 'filed'.
Filing Stats: 305 words · 1 min read · ~1 pages · Grade level 10.9 · Accepted 2024-12-18 08:32:23
Filing Documents
- ea022499901-6k_alphatau.htm (6-K) — 12KB
- ea022499901ex99-1_alphatau.htm (EX-99.1) — 9KB
- 0001213900-24-109950.txt ( ) — 21KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Alpha Tau Medical Ltd. Date: December 18, 2024 By: /s/ Uzi Sofer Uzi Sofer Chief Executive Officer 3